Backgrounds/Aims: After centralization policy, clinical outcomes have been improved in patients underwent pancreaticoduodenectomy for pancreatic cancer. However, centralization could exacerbate the prolongation of surgical waiting time. This study aims to investigate whether the shorter waiting time correlates with the better survival and to identify the major confounders that influence the association between those. Methods: In this retrospective cohort study, a total 554 patients with pathologically confirmed pancreatic ductal adenocarcinoma were assessed the eligibility from 2014 through 2015. Patients with neoadjuvant chemotherapy, body-tail resection, total pancreatectomy and combined adjacent organ resection were excluded. All patients were divided into two groups by median waiting time, 21 days, defined as the date difference between initial imaging diagnosis and operation. 
INTRODUCTION
With recent development in management, pancreatic cancer has shown significant improvement in prognosis. 1 Surgery still represents the only potentially curative treatment, and many innovations have been suggested to improve the clinical outcome of pancreatic cancer. 2 Hospital volume, in other words, centralization, is one of those innovations, and several studies have reported an association between hospital volume and clinical outcome. 3, 4 However, centralization could exacerbate a potential weakness: the prolongation of surgical waiting time.
Delayed surgical resection for tumors can adversely affect tumor stage and survival in other types of cancer surgery, including lung, breast and colorectal cancers. [5] [6] [7] Several reports have investigated the association between pancreatic cancer surgical waiting time and clinical outcome, but the answer is still controversial. [8] [9] [10] Extra-large hospitals are congested with the majority of patients, and this phenomenon might be more prominent in pancreatic cancer. 11 However, clinically relevant data regarding the potential impact of surgical waiting times are lacking.
Therefore, we hypothesized that a short waiting time is correlated with better survival outcome than a long waiting time in patients who undergo pancreaticoduodenectomy (PD) for curative resection of pancreatic ductal adenocarcinoma (PDAC). The aim of this study is to in- 
MATERIALS AND METHODS
The present study is a retrospective cohort study of patients who underwent standard PD for pathologically con- For the patients in this cohort, overall survival was defined as a primary outcome. Overall survival was commonly defined as the time between operation and death.
We censored the patients who were alive at the end of the study (August 15, 2018) and those who could not be Statistical analysis was conducted using R 3.5. (Fig. 3) .
To investigate the possible trends in surgical waiting In the era of centralization policy, much strong evidence supports the key role played by surgical volume in positively affecting the short-term and long-term outcomes. [16] [17] [18] When the patients are centralized to referral centers, the prolongation of surgical waiting time might be an inevitable consequence. The delay in treatment can affect patient survival. 5, 6, 9 From this concept, some national health care systems recommend that the patients with an overt or suspected malignancy must be operated within a specific number of days from surgical consultation. 8, 19 However, one previous study revealed that more than 13% of surgery patients in Korea had experienced more than 30 days of waiting and that patients at high-volume hospitals waited longer for surgery than those in low-to medium-volume centers. 10 Our study found 41 patients (22.3%) who waited on surgery more than 30 days, and this may reflect changes in health care
service utilization with time.
Although this study could not prove the effect of surgical waiting time on survival, the patients with greater waiting time may have been more ill or presented with more advanced disease, which could require more ag- 
